留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

一种大鼠心脏全器官灌注脱细胞方案及其脱细胞效果评价

孙志刚 解影 李海慧 申国争 刘学刚

孙志刚, 解影, 李海慧, 申国争, 刘学刚. 一种大鼠心脏全器官灌注脱细胞方案及其脱细胞效果评价[J]. 中华全科医学, 2023, 21(4): 593-597. doi: 10.16766/j.cnki.issn.1674-4152.002938
引用本文: 孙志刚, 解影, 李海慧, 申国争, 刘学刚. 一种大鼠心脏全器官灌注脱细胞方案及其脱细胞效果评价[J]. 中华全科医学, 2023, 21(4): 593-597. doi: 10.16766/j.cnki.issn.1674-4152.002938
SUN Zhigang, XIE Ying, LI Haihui, SHEN Guozheng, LIU Xuegang. An acellular protocol of whole organ perfusion in rat heart and evaluation of its acellular effect[J]. Chinese Journal of General Practice, 2023, 21(4): 593-597. doi: 10.16766/j.cnki.issn.1674-4152.002938
Citation: SUN Zhigang, XIE Ying, LI Haihui, SHEN Guozheng, LIU Xuegang. An acellular protocol of whole organ perfusion in rat heart and evaluation of its acellular effect[J]. Chinese Journal of General Practice, 2023, 21(4): 593-597. doi: 10.16766/j.cnki.issn.1674-4152.002938

一种大鼠心脏全器官灌注脱细胞方案及其脱细胞效果评价

doi: 10.16766/j.cnki.issn.1674-4152.002938
基金项目: 

安徽高校自然科学研究项目 KJ2019A0362

详细信息
    通讯作者:

    刘学刚,E-mail: XGLiu99@126.com

  • 中图分类号: R654.2  R-332

An acellular protocol of whole organ perfusion in rat heart and evaluation of its acellular effect

  • 摘要:   目的  用一种新的灌注脱细胞方案对离体SD大鼠心脏进行脱细胞处理,对其脱细胞效果进行检测与评估。  方法  取12只2月龄同窝雄性SD大鼠,按随机数字表法分为脱细胞组和对照组,每组6只。将各组大鼠麻醉并行全身肝素化后取出心脏。取脱细胞组心脏称取重量,然后将灌注针逆行插入升主动脉,连接好灌注装置进行脱细胞,观察脱细胞过程中心脏外观的变化,结束后称取脱细胞后的质量。在各心脏左心耳、右心耳、心尖部及右室流出道的同一部位取少量组织测定dsDNA含量,余组织制作石蜡切片并行HE染色及Masson染色后采集图像分析。  结果  脱细胞过程中,心脏颜色逐渐变得淡红,再变得相对透明,最后变成乳白色,肉眼可见冠脉血管结构保存完好。脱细胞组脱细胞前后心脏质量分别为(1.27±0.03)g、(0.49±0.02)g,差异有统计学意义(t=111.164, P < 0.001)。2组心脏各处测得的dsDNA含量差异均有统计学意义(均P < 0.01),且脱细胞组各处测得的dsDNA含量均显著低于50 ng/mg。对照组心脏HE染色切片及Masson染色切片均可见典型的心肌组织切片图像。而脱细胞组HE染色切片及Masson染色切片图像呈网状,均无明显细胞及核结构,其内可见冠状动脉轮廓。  结论  该脱细胞方案操作简单,效果可靠,是一种较为理想的心脏全器官脱细胞生物支架制备方案。

     

  • 图  1  脱细胞过程心脏变化情况

    注:图中箭头表示脱细胞步骤,数字1~9表示具体试剂,其前后图片分别表示经该步骤处理前后心脏照片。1~9具体表示为:1为去离子水30 mL;2为PBS 60 mL;3为0.05% EDTA和0.02%胰蛋白酶混合液60 mL;4为1% SDS 30 mL;5为0.05% EDTA和3% Triton X-100混合液30 mL;6为2.4%去氧胆酸30 mL;7为4%乙醇和0.1%过氧乙酸混合液30 mL;8为PBS 60 mL;9为去离子水60 mL。

    Figure  1.  Cardiac changes during decellularization

    图  2  2组心脏心肌切片HE染色图像比较(×400)

    注:A为对照组心肌切片HE染色图,可见心肌细胞纤维及细胞基质被染成红色(红色箭头所指),细胞核被染成蓝色(蓝色箭头所指);B为脱细胞组心肌切片HE染色图,图中未见明显心肌细胞及细胞核结构,仅可见被染成淡红色网格状结构。

    Figure  2.  Comparison of HE staining images of cardiac myocardial slices between the two groups (×400)

    图  3  2组心脏心肌切片Masson染色图像比较(×400)

    注:A为对照心肌切片Masson染色图,心肌细胞被染成红色(红色箭头所指),细胞核被染成蓝黑色(黑色箭头所指),胶原纤维被染成蓝色(蓝色箭头所指),其中可见冠状动脉结构(白色箭头所指)。B为脱细胞后心肌切片Masson染色图,未见明显的心肌细胞及核结构,可见被染成蓝色的胶原纤维及保存较完好的冠状动脉结构。

    Figure  3.  Comparison of Masson stained images of heart myocardial sections between the two groups(×400)

  • [1] 陈康玉, 严激. 安徽多中心前瞻性心力衰竭队列基线分析[J]. 中华全科医学, 2022, 20(1): 14-17. doi: 10.16766/j.cnki.issn.1674-4152.002265

    CHEN K Y, YAN J. Baseline analysis of a multicenter prospective heart-failure cohort in Anhui Province[J]. Chinese Journal of General Practice, 2022, 20(1): 14-17. doi: 10.16766/j.cnki.issn.1674-4152.002265
    [2] POTENA L, ZUCKERMANN A, BARBERINI F, et al. Complications of cardiac transplantation[J]. Curr Cardiol Rep, 2018, 20(9) : 73. doi: 10.1007/s11886-018-1018-3
    [3] 叶真, 仲崇山. 人工心脏, 让心衰患者重获"心"生[N]. 新华日报, (2021-11-16)[2022-03-12]. https://kns.cnki.net/kcms/detail/detail.aspx?FileName=XHRB202111160132&DbName=CCND2021.

    YE Z, ZHONG C S. Artificial heart gives heart failure patients a new lease of life[N]. Xinhua Daily, (2021-11-16)[2022-03-12]. https://kns.cnki.net/kcms/detail/detail.aspx?FileName=XHRB202111160132&DbName=CCND2021.
    [4] OTT H C, MATTHIESEN T S, GOH S K, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart[J]. Nat Med, 2008, 14(2): 213-221. doi: 10.1038/nm1684
    [5] KARAMANOS N K, THEOCHARIS A D, PIPERIGKOU Z, et al. A guide to the composition and functions of the extracellular matrix[J]. FEBS J, 2021, 288(24): 6850-6912. doi: 10.1111/febs.15776
    [6] TAN Y H, HELMS H R, NAKAYAMA K H. Decellularization strategies for regenerating cardiac and skeletal muscle tissues[J]. Front Bioeng Biotechnol, 2022, 10: 831300. DOI: 10.3389/fbioe.2022.831300.
    [7] KEANE T J, LONDONO R, TURNER N J, et al. Consequences of ineffective decellularization of biologic scaffolds on the host response[J]. Biomaterials, 2011, 33(6): 1771-1781. http://www.researchgate.net/profile/Tim_Keane4/publication/51849338_Consequences_of_ineffective_decellularization_of_biologic_scaffolds_on_the_host_response/links/553a26e00cf29b5ee4b4502c.pdf
    [8] TANG-QUAN K R, MEHTA N A, SAMPAIO L C, et al. Whole cardiac tissue bioscaffolds[M]//Cham: Springer International Publishing, 2018: 85-114.
    [9] DAL SASSO E, MENABÒ R, AGRILLO D, et al. Regen heart: a time-effective, low-concentration, detergent-based method aiming for conservative decellularization of the whole heart organ[J]. ACS Biomater Sci Eng, 2020, 6(10): 5493-5506. doi: 10.1021/acsbiomaterials.0c00540
    [10] ZHANG X W, CHEN X, HONG H, et al. Decellularized extracellular matrix scaffolds: recent trends and emerging strategies in tissue engineering[J]. Bioact Mater, 2022, 10: 15-31. doi: 10.1016/j.bioactmat.2021.09.014
    [11] HODGSON M J, KNUTSON C C, MOMTAHAN N, et al. Extracellular matrix from whole porcine heart decellularization for cardiac tissue engineering[J]. Methods Mol Biol, 2018, 1577: 95-102.
    [12] CRAPO P M, GILBERT T W, BADYLAK S F. An overview of tissue and whole organ decellularization processes[J]. Biomaterials, 2011, 32(12): 3233-3243. doi: 10.1016/j.biomaterials.2011.01.057
    [13] 万峰, 封云震. 心力衰竭的外科治疗新进展[J]. 中国心血管病研究, 2021, 19(12): 1062-1066. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGZ202112002.htm

    WAN F, FENG Y Z. Advances in surgical treatment of heart failure[J]. Chinese Journal of Cardiovascular Research, 2021, 19(12): 1062-1066. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGZ202112002.htm
    [14] SILVA A C, RODRIGUES S C, CALDEIRA J, et al. Three-dimensional scaffolds of fetal decellularized hearts exhibit enhanced potential to support cardiac cells in comparison to the adult[J]. Biomaterials, 2016, 104: 52-64. doi: 10.1016/j.biomaterials.2016.06.062
    [15] TAYLOR D A. The future of tissue engineering in heart transplantation[J]. Tex Heart Inst J, 2019, 46(1): 73-74. doi: 10.14503/THIJ-18-6748
    [16] TAYLOR D A, FRAZIER O H, ELGALAD A, et al. Building a total bioartificial heart: harnessing nature to overcome the current hurdles[J]. Artif Organs, 2018, 42(10): 970-982. doi: 10.1111/aor.13336
    [17] MENDIBIL U, RUIZ-HERNANDEZ R, RETEGI-CARRION S, et al. Tissue-specific decellularization methods: rationale and strategies to achieve regenerative compounds[J]. Int J Mol Sci, 2020, 21(15), 5447. doi: 10.3390/ijms21155447
    [18] TAO Z W, MOHAMED M, HOGAN M, et al. Establishing the framework for fabrication of a bioartificial heart[J]. Asaio J, 2015, 61(4): 429-436. doi: 10.1097/MAT.0000000000000233
    [19] LEE P F, CHAU E, CABELLO R, et al. Inverted orientation improves decellularization of whole porcine hearts[J]. Acta Biomater, 2017, 49: 181-191. doi: 10.1016/j.actbio.2016.11.047
    [20] GARRETA E, ORIA R, TARANTINO C, et al. Tissue engineering by decellularization and 3D bioprinting[J]. Mater Today, 2017, 20(4): 166-178. doi: 10.1016/j.mattod.2016.12.005
  • 加载中
图(3)
计量
  • 文章访问数:  198
  • HTML全文浏览量:  34
  • PDF下载量:  14
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-11-15
  • 网络出版日期:  2023-05-31

目录

    /

    返回文章
    返回